Granahan Investment Management LLC grew its stake in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 26.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,782,215 shares of the company's stock after purchasing an additional 589,485 shares during the quarter. Granahan Investment Management LLC owned approximately 2.33% of SunOpta worth $21,423,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the company. Bayesian Capital Management LP grew its position in shares of SunOpta by 15.2% in the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock worth $89,000 after acquiring an additional 1,523 shares in the last quarter. Ironwood Investment Management LLC raised its holdings in shares of SunOpta by 1.2% during the fourth quarter. Ironwood Investment Management LLC now owns 132,879 shares of the company's stock worth $1,023,000 after purchasing an additional 1,549 shares during the period. Quadrant Capital Group LLC lifted its position in shares of SunOpta by 15.2% in the 4th quarter. Quadrant Capital Group LLC now owns 14,542 shares of the company's stock worth $112,000 after buying an additional 1,923 shares during the last quarter. EP Wealth Advisors LLC grew its position in shares of SunOpta by 18.7% during the 4th quarter. EP Wealth Advisors LLC now owns 14,730 shares of the company's stock valued at $113,000 after buying an additional 2,316 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in SunOpta by 2.5% during the fourth quarter. Rhumbline Advisers now owns 140,310 shares of the company's stock worth $1,080,000 after acquiring an additional 3,402 shares during the period. 85.39% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, SVP Bryan P. Clark sold 8,500 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $5.32, for a total transaction of $45,220.00. Following the completion of the transaction, the senior vice president now owns 28,150 shares of the company's stock, valued at $149,758. This trade represents a 23.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.90% of the stock is owned by insiders.
SunOpta Stock Performance
Shares of STKL traded down $0.04 during mid-day trading on Thursday, reaching $6.14. 326,350 shares of the company's stock traded hands, compared to its average volume of 762,045. SunOpta Inc. has a 12 month low of $3.65 and a 12 month high of $8.11. The stock has a market capitalization of $721.12 million, a P/E ratio of -34.08 and a beta of 1.50. The business's 50-day moving average price is $4.73 and its 200-day moving average price is $6.44. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.53 and a current ratio of 1.20.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.04 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.02. The company had revenue of $201.63 million for the quarter, compared to analyst estimates of $195.09 million. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. Equities analysts predict that SunOpta Inc. will post 0.13 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded SunOpta from a "sell" rating to a "hold" rating in a research report on Tuesday, March 11th.
View Our Latest Analysis on STKL
SunOpta Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Read More

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.